HEADER HYDROLASE 12-SEP-18 6HMM TITLE POLYADPRIBOSYL GLYCOHYDROLASE IN COMPLEX WITH PDD00013907 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY(ADP-RIBOSE) GLYCOHYDROLASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.143; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: CYSTEINES 268 AND 500 HAVE BECOME SINGLY OXIDISED COMPND 8 DURING PURIFICATION/ CRYSTALLISATION (IE MICROHETEROGENEITY) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET28B KEYWDS HYDROLASE, COMPETITIVE INHIBITOR, PARG EXPDTA X-RAY DIFFRACTION AUTHOR J.A.TUCKER,C.BRASSINGTON,G.HASSALL REVDAT 4 24-JAN-24 6HMM 1 REMARK REVDAT 3 24-APR-19 6HMM 1 JRNL REVDAT 2 21-NOV-18 6HMM 1 JRNL REVDAT 1 14-NOV-18 6HMM 0 JRNL AUTH B.WASZKOWYCZ,K.M.SMITH,A.E.MCGONAGLE,A.M.JORDAN,B.ACTON, JRNL AUTH 2 E.E.FAIRWEATHER,L.A.GRIFFITHS,N.M.HAMILTON,N.S.HAMILTON, JRNL AUTH 3 J.R.HITCHIN,C.P.HUTTON,D.I.JAMES,C.D.JONES,S.JONES, JRNL AUTH 4 D.P.MOULD,H.F.SMALL,A.I.J.STOWELL,J.A.TUCKER,I.D.WADDELL, JRNL AUTH 5 D.J.OGILVIE JRNL TITL CELL-ACTIVE SMALL MOLECULE INHIBITORS OF THE DNA-DAMAGE JRNL TITL 2 REPAIR ENZYME POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG): JRNL TITL 3 DISCOVERY AND OPTIMIZATION OF ORALLY BIOAVAILABLE JRNL TITL 4 QUINAZOLINEDIONE SULFONAMIDES. JRNL REF J.MED.CHEM. V. 61 10767 2018 JRNL REFN ISSN 0022-2623 JRNL PMID 30403352 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01407 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 44100 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 2246 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.95 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.03 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2396 REMARK 3 BIN R VALUE (WORKING SET) : 0.3475 REMARK 3 BIN FREE R VALUE : 0.4276 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 113 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4062 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 55 REMARK 3 SOLVENT ATOMS : 525 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.08570 REMARK 3 B22 (A**2) : -1.06380 REMARK 3 B33 (A**2) : -3.02190 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.307 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.181 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.169 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.166 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.162 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HMM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-SEP-18. REMARK 100 THE DEPOSITION ID IS D_1200011902. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : RIGAKU VARIMAXHF REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45150 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.890 REMARK 200 RESOLUTION RANGE LOW (A) : 95.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.45700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4A0D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MIX PURIFIED PROTEIN IN 50 MM HEPES, REMARK 280 PH 7.0, 150 MM NACL, 2 MM DTT AT 7.5 MG/ML WITH A PRECIPITANT REMARK 280 CONSISTING OF 28% PEG-3350, 0.2 M MAGNESIUM CHLORIDE, 0.1 M PCTP REMARK 280 (0.04 M SODIUM PROPIONATE, 0.02 M SODIUM CACODYLATE, 0.04 M BIS- REMARK 280 TRIS PROPANE) PH 7.5., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.54050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.70500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.18350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.70500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.54050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.18350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 446 REMARK 465 SER A 447 REMARK 465 SER A 448 REMARK 465 PRO A 449 REMARK 465 GLU A 524 REMARK 465 ASP A 525 REMARK 465 GLU A 526 REMARK 465 ASN A 527 REMARK 465 GLY A 528 REMARK 465 GLU A 529 REMARK 465 ARG A 530 REMARK 465 ALA A 964 REMARK 465 GLU A 965 REMARK 465 THR A 966 REMARK 465 ALA A 967 REMARK 465 ASP A 968 REMARK 465 HIS A 969 REMARK 465 SER A 970 REMARK 465 GLY A 971 REMARK 465 GLN A 972 REMARK 465 ARG A 973 REMARK 465 THR A 974 REMARK 465 GLY A 975 REMARK 465 THR A 976 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 450 CG OD1 OD2 REMARK 470 LYS A 451 CD CE NZ REMARK 470 ARG A 470 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 503 CG CD CE NZ REMARK 470 LYS A 566 CG CD CE NZ REMARK 470 LYS A 648 CG CD CE NZ REMARK 470 ARG A 800 CD NE CZ NH1 NH2 REMARK 470 GLU A 810 CG CD OE1 OE2 REMARK 470 ARG A 830 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 831 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 922 CD CE NZ REMARK 470 LYS A 951 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 470 113.69 -30.18 REMARK 500 ASN A 561 43.69 -147.66 REMARK 500 CYS A 608 78.02 -100.19 REMARK 500 SER A 749 -120.21 -136.10 REMARK 500 LEU A 752 45.74 -156.84 REMARK 500 VAL A 753 -161.38 -106.55 REMARK 500 ALA A 796 -120.15 48.52 REMARK 500 SER A 802 -62.54 -96.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1614 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A1615 DISTANCE = 6.01 ANGSTROMS REMARK 525 HOH A1616 DISTANCE = 6.30 ANGSTROMS REMARK 525 HOH A1617 DISTANCE = 6.39 ANGSTROMS REMARK 525 HOH A1618 DISTANCE = 6.42 ANGSTROMS REMARK 525 HOH A1619 DISTANCE = 6.89 ANGSTROMS REMARK 525 HOH A1620 DISTANCE = 7.08 ANGSTROMS REMARK 525 HOH A1621 DISTANCE = 7.42 ANGSTROMS REMARK 525 HOH A1622 DISTANCE = 7.87 ANGSTROMS REMARK 525 HOH A1623 DISTANCE = 10.90 ANGSTROMS REMARK 525 HOH A1624 DISTANCE = 11.42 ANGSTROMS REMARK 525 HOH A1625 DISTANCE = 15.28 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7JB A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1007 DBREF 6HMM A 448 976 UNP Q86W56 PARG_HUMAN 448 976 SEQADV 6HMM GLY A 446 UNP Q86W56 EXPRESSION TAG SEQADV 6HMM SER A 447 UNP Q86W56 EXPRESSION TAG SEQADV 6HMM ALA A 616 UNP Q86W56 LYS 616 ENGINEERED MUTATION SEQADV 6HMM ALA A 617 UNP Q86W56 GLN 617 ENGINEERED MUTATION SEQADV 6HMM ALA A 618 UNP Q86W56 LYS 618 ENGINEERED MUTATION SEQADV 6HMM ALA A 688 UNP Q86W56 GLU 688 ENGINEERED MUTATION SEQADV 6HMM ALA A 689 UNP Q86W56 LYS 689 ENGINEERED MUTATION SEQADV 6HMM ALA A 690 UNP Q86W56 LYS 690 ENGINEERED MUTATION SEQRES 1 A 531 GLY SER SER PRO ASP LYS LYS TRP LEU GLY THR PRO ILE SEQRES 2 A 531 GLU GLU MET ARG ARG MET PRO ARG CYS GLY ILE ARG LEU SEQRES 3 A 531 PRO LEU LEU ARG PRO SER ALA ASN HIS THR VAL THR ILE SEQRES 4 A 531 ARG VAL ASP LEU LEU ARG ALA GLY GLU VAL PRO LYS PRO SEQRES 5 A 531 PHE PRO THR HIS TYR LYS ASP LEU TRP ASP ASN LYS HIS SEQRES 6 A 531 VAL LYS MET PRO CYS SER GLU GLN ASN LEU TYR PRO VAL SEQRES 7 A 531 GLU ASP GLU ASN GLY GLU ARG THR ALA GLY SER ARG TRP SEQRES 8 A 531 GLU LEU ILE GLN THR ALA LEU LEU ASN LYS PHE THR ARG SEQRES 9 A 531 PRO GLN ASN LEU LYS ASP ALA ILE LEU LYS TYR ASN VAL SEQRES 10 A 531 ALA TYR SER LYS LYS TRP ASP PHE THR ALA LEU ILE ASP SEQRES 11 A 531 PHE TRP ASP LYS VAL LEU GLU GLU ALA GLU ALA GLN HIS SEQRES 12 A 531 LEU TYR GLN SER ILE LEU PRO ASP MET VAL LYS ILE ALA SEQRES 13 A 531 LEU CYS LEU PRO ASN ILE CYS THR GLN PRO ILE PRO LEU SEQRES 14 A 531 LEU ALA ALA ALA MET ASN HIS SER ILE THR MET SER GLN SEQRES 15 A 531 GLU GLN ILE ALA SER LEU LEU ALA ASN ALA PHE PHE CYS SEQRES 16 A 531 THR PHE PRO ARG ARG ASN ALA LYS MET LYS SER GLU TYR SEQRES 17 A 531 SER SER TYR PRO ASP ILE ASN PHE ASN ARG LEU PHE GLU SEQRES 18 A 531 GLY ARG SER SER ARG LYS PRO GLU LYS LEU LYS THR LEU SEQRES 19 A 531 PHE CYS TYR PHE ARG ARG VAL THR ALA ALA ALA PRO THR SEQRES 20 A 531 GLY LEU VAL THR PHE THR ARG GLN SER LEU GLU ASP PHE SEQRES 21 A 531 PRO GLU TRP GLU ARG CSO GLU LYS PRO LEU THR ARG LEU SEQRES 22 A 531 HIS VAL THR TYR GLU GLY THR ILE GLU GLU ASN GLY GLN SEQRES 23 A 531 GLY MET LEU GLN VAL ASP PHE ALA ASN ARG PHE VAL GLY SEQRES 24 A 531 GLY GLY VAL THR SER ALA GLY LEU VAL GLN GLU GLU ILE SEQRES 25 A 531 ARG PHE LEU ILE ASN PRO GLU LEU ILE ILE SER ARG LEU SEQRES 26 A 531 PHE THR GLU VAL LEU ASP HIS ASN GLU CYS LEU ILE ILE SEQRES 27 A 531 THR GLY THR GLU GLN TYR SER GLU TYR THR GLY TYR ALA SEQRES 28 A 531 GLU THR TYR ARG TRP SER ARG SER HIS GLU ASP GLY SER SEQRES 29 A 531 GLU ARG ASP ASP TRP GLN ARG ARG CYS THR GLU ILE VAL SEQRES 30 A 531 ALA ILE ASP ALA LEU HIS PHE ARG ARG TYR LEU ASP GLN SEQRES 31 A 531 PHE VAL PRO GLU LYS MET ARG ARG GLU LEU ASN LYS ALA SEQRES 32 A 531 TYR CYS GLY PHE LEU ARG PRO GLY VAL SER SER GLU ASN SEQRES 33 A 531 LEU SER ALA VAL ALA THR GLY ASN TRP GLY CYS GLY ALA SEQRES 34 A 531 PHE GLY GLY ASP ALA ARG LEU LYS ALA LEU ILE GLN ILE SEQRES 35 A 531 LEU ALA ALA ALA ALA ALA GLU ARG ASP VAL VAL TYR PHE SEQRES 36 A 531 THR PHE GLY ASP SER GLU LEU MET ARG ASP ILE TYR SER SEQRES 37 A 531 MET HIS ILE PHE LEU THR GLU ARG LYS LEU THR VAL GLY SEQRES 38 A 531 ASP VAL TYR LYS LEU LEU LEU ARG TYR TYR ASN GLU GLU SEQRES 39 A 531 CYS ARG ASN CSO SER THR PRO GLY PRO ASP ILE LYS LEU SEQRES 40 A 531 TYR PRO PHE ILE TYR HIS ALA VAL GLU SER CYS ALA GLU SEQRES 41 A 531 THR ALA ASP HIS SER GLY GLN ARG THR GLY THR MODRES 6HMM CSO A 711 CYS MODIFIED RESIDUE MODRES 6HMM CSO A 943 CYS MODIFIED RESIDUE HET CSO A 711 7 HET CSO A 943 7 HET DMS A1001 4 HET GOL A1002 6 HET GOL A1003 6 HET 7JB A1004 24 HET SO4 A1005 5 HET SO4 A1006 5 HET SO4 A1007 5 HETNAM CSO S-HYDROXYCYSTEINE HETNAM DMS DIMETHYL SULFOXIDE HETNAM GOL GLYCEROL HETNAM 7JB ~{N}-~{TERT}-BUTYL-9,10-BIS(OXIDANYLIDENE)ANTHRACENE-2- HETNAM 2 7JB SULFONAMIDE HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 2 DMS C2 H6 O S FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 7JB C18 H17 N O4 S FORMUL 6 SO4 3(O4 S 2-) FORMUL 9 HOH *525(H2 O) HELIX 1 AA1 PRO A 457 MET A 461 5 5 HELIX 2 AA2 ARG A 485 LEU A 489 5 5 HELIX 3 AA3 ARG A 535 LEU A 544 1 10 HELIX 4 AA4 ARG A 549 TYR A 560 1 12 HELIX 5 AA5 ASN A 561 SER A 565 5 5 HELIX 6 AA6 PHE A 570 VAL A 580 1 11 HELIX 7 AA7 GLU A 582 SER A 592 1 11 HELIX 8 AA8 SER A 592 CYS A 603 1 12 HELIX 9 AA9 CYS A 603 CYS A 608 1 6 HELIX 10 AB1 GLN A 627 PHE A 639 1 13 HELIX 11 AB2 PHE A 661 GLU A 666 5 6 HELIX 12 AB3 ARG A 671 ALA A 689 1 19 HELIX 13 AB4 GLU A 707 CSO A 711 5 5 HELIX 14 AB5 THR A 725 GLY A 730 1 6 HELIX 15 AB6 VAL A 753 ASN A 762 1 10 HELIX 16 AB7 PRO A 763 ILE A 766 5 4 HELIX 17 AB8 ILE A 767 THR A 772 1 6 HELIX 18 AB9 TYR A 795 TYR A 799 5 5 HELIX 19 AC1 ARG A 831 PHE A 836 5 6 HELIX 20 AC2 VAL A 837 LEU A 853 1 17 HELIX 21 AC3 SER A 858 LEU A 862 5 5 HELIX 22 AC4 ASP A 878 ALA A 893 1 16 HELIX 23 AC5 ASP A 904 ARG A 921 1 18 HELIX 24 AC6 THR A 924 CYS A 940 1 17 HELIX 25 AC7 LYS A 951 SER A 962 1 12 SHEET 1 AA110 TRP A 453 GLY A 455 0 SHEET 2 AA110 LEU A 718 THR A 721 -1 O VAL A 720 N LEU A 454 SHEET 3 AA110 VAL A 897 PHE A 900 1 O TYR A 899 N HIS A 719 SHEET 4 AA110 VAL A 865 GLY A 868 1 N VAL A 865 O VAL A 898 SHEET 5 AA110 LEU A 734 ALA A 739 1 N LEU A 734 O ALA A 866 SHEET 6 AA110 GLU A 820 ASP A 825 1 O GLU A 820 N GLN A 735 SHEET 7 AA110 GLU A 779 THR A 784 -1 N ILE A 783 O ILE A 821 SHEET 8 AA110 LEU A 694 SER A 701 -1 N THR A 698 O ILE A 782 SHEET 9 AA110 HIS A 621 SER A 626 -1 N HIS A 621 O ARG A 699 SHEET 10 AA110 HIS A 480 VAL A 482 1 N THR A 481 O THR A 624 SHEET 1 AA2 2 LEU A 520 TYR A 521 0 SHEET 2 AA2 2 GLY A 533 SER A 534 -1 O GLY A 533 N TYR A 521 SHEET 1 AA3 2 SER A 790 THR A 793 0 SHEET 2 AA3 2 ARG A 800 SER A 804 -1 O SER A 802 N GLU A 791 LINK C ARG A 710 N CSO A 711 1555 1555 1.35 LINK C CSO A 711 N GLU A 712 1555 1555 1.35 LINK C ASN A 942 N CSO A 943 1555 1555 1.35 LINK C CSO A 943 N SER A 944 1555 1555 1.35 CISPEP 1 MET A 464 PRO A 465 0 -2.59 CISPEP 2 PHE A 498 PRO A 499 0 3.99 SITE 1 AC1 2 TYR A 502 CYS A 515 SITE 1 AC2 7 PRO A 476 VAL A 482 ILE A 484 ARG A 485 SITE 2 AC2 7 VAL A 486 PHE A 498 HOH A1207 SITE 1 AC3 10 GLU A 709 ARG A 710 CSO A 711 GLU A 712 SITE 2 AC3 10 THR A 924 GLY A 926 ASP A 927 LYS A 930 SITE 3 AC3 10 HOH A1162 HOH A1271 SITE 1 AC4 8 THR A 725 ILE A 726 GLU A 727 GLN A 754 SITE 2 AC4 8 ARG A 758 TYR A 792 TYR A 795 PHE A 902 SITE 1 AC5 8 ARG A 535 TYR A 564 PRO A 643 ARG A 644 SITE 2 AC5 8 ASN A 646 ARG A 941 ASN A 942 HOH A1200 SITE 1 AC6 2 TRP A 506 ARG A 644 SITE 1 AC7 7 ARG A 535 LEU A 538 LYS A 559 TYR A 560 SITE 2 AC7 7 ASN A 561 VAL A 562 HOH A1374 CRYST1 67.081 90.367 95.410 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014907 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011066 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010481 0.00000